USANA Health Sciences (USNA)

NYSE Market Closed

USANA Health Sciences Inc. develops, manufactures, and sells nutritional supplements, functional foods, personal care products, and skincare items. The company focuses on health and wellness products, with an emphasis on science-based formulations intended to support nutrition, healthy living, and everyday personal care. Its portfolio includes vitamins, minerals, dietary supplements, meal and food products, and topical products sold under the USANA brand.

The company’s core nutritional business is organized around several operating areas, including buy-sell markets, China, and India, and it also reports a Hiya direct-to-consumer segment. Hiya expands USANA’s reach into children’s wellness products through an online consumer model, while the legacy business is known for direct selling and distributor-led customer relationships in many markets. This structure gives the company exposure to both traditional relationship-based wellness sales and newer digital commerce channels.

USANA operates internationally, with activity across Asia Pacific, the Americas, and Europe. Asia Pacific, particularly Greater China, is an important contributor to revenue and a key region for the company’s growth profile. As a result, the business is influenced by consumer health trends, local regulations governing supplements and direct selling, currency movements, and economic conditions in its major markets.

For investors, USNA represents a specialized consumer health and wellness company rather than a broad packaged-goods manufacturer. Its distinguishing features are in-house product development and manufacturing, a global direct-sales footprint, and a product mix centered on nutritional supplementation. The company’s performance depends on brand trust, distributor and customer engagement, regulatory compliance, and the continued appeal of wellness-oriented products in both established and emerging markets.

18.13 USD
16.15 USD
+0.67 (+3.84%)
After-hours

Last updated

Market Cap
334.73M
P/E
37.73
P/FCF
113.05
P/S
0.36
Enterprise Value
185.98M
Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Address
3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336
GlobeNewswire Inc.

Women Health & Beauty Supplements Market Analysis and Growth Forecast 2026-2030

19 Jan 2026, 15:26 PM
Zacks Investment Research

USNA or ZTS: Which Is the Better Value Stock Right Now?

21 Jun 2024, 21:10 PM
Zacks Investment Research

USNA vs. ZTS: Which Stock Is the Better Value Option?

05 Jun 2024, 21:10 PM
Zacks Investment Research

USNA vs. STVN: Which Stock Should Value Investors Buy Now?

20 May 2024, 21:10 PM
Zacks Investment Research

USNA or STVN: Which Is the Better Value Stock Right Now?

02 May 2024, 21:10 PM
Zacks Investment Research

USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates

01 May 2024, 03:25 AM
Zacks Investment Research

USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates

07 Feb 2024, 04:45 AM
Zacks Investment Research

USANA Health Sciences (USNA) Q3 Earnings Miss Estimates

25 Oct 2023, 03:00 AM
Zacks Investment Research

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

19 Oct 2023, 19:31 PM
Zacks Investment Research

Earnings Preview: USANA Health Sciences (USNA) Q3 Earnings Expected to Decline

17 Oct 2023, 19:30 PM
Zacks Investment Research

USNA or STVN: Which Is the Better Value Stock Right Now?

11 Oct 2023, 21:10 PM
Zacks Investment Research

USNA vs. ZTS: Which Stock Is the Better Value Option?

13 Sept 2023, 21:10 PM
Zacks Investment Research

USNA vs. ZTS: Which Stock Should Value Investors Buy Now?

28 Aug 2023, 21:10 PM
Zacks Investment Research

USNA or ZTS: Which Is the Better Value Stock Right Now?

10 Aug 2023, 21:10 PM
Zacks Investment Research

USANA Health Sciences (USNA) Tops Q2 Earnings and Revenue Estimates

26 Jul 2023, 03:15 AM
Zacks Investment Research

All You Need to Know About USANA Health (USNA) Rating Upgrade to Buy

27 Apr 2023, 21:30 PM
Investing.com

USANA Stock Could Bottom Soon

24 Jan 2023, 11:46 AM
MarketWatch

Usana sees sales bump in China, but 2023 still uncertain

06 Jan 2023, 03:36 AM
Zacks Investment Research

USANA Health Sciences (USNA) Q2 Earnings and Revenues Lag Estimates

27 Jul 2022, 04:35 AM
Zacks Investment Research

Analysts Estimate USANA Health Sciences (USNA) to Report a Decline in Earnings: What to Look Out for

19 Jul 2022, 19:31 PM
Market Cap
334.73M
Enterprise Value
185.98M
P/E
37.73
P/B
0.62
P/S
0.36
EV / EBITDA
2.28
EV / Sales
0.2
EPS
0.48
Dividend Yield
0.41%
P/FCF
113.05
P/CF
20.13
Free Cash Flow
2.96M
ROE
1.63%
ROA
1.2%
Debt / Equity
0.03
Current Ratio
2.51
Quick Ratio
1.69
Cash
1.39
Avg Volume
112.87K
Fundamentals Snapshot Price
18.13

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 250.22M 226.2M 213.67M 235.85M 249.54M
Gross profit 190.78M 176.79M 164.86M 185.66M 197.09M
Operating income 13.87M 3.82M 1.22M 16.72M 15.67M
EBITDA 22.15M 25.81M 9.11M 24.49M 24.01M
Net income 7.52M -1.78M -6.52M 9.66M 9.4M
Basic EPS 0.41 -0.09 -0.36 0.52 0.49
Diluted EPS 0.41 -0.09 -0.36 0.52 0.49

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 738.97M 742.92M 726.59M 734.53M 746.6M
Total liabilities 144.18M 156.64M 145.04M 148.97M 162.72M
Total equity 543.55M 533.1M 528.07M 531.06M 529.76M
Cash & equivalents 162.75M 158.38M 145.35M 151.34M 179.61M
Current assets 294.23M 288.41M 264.07M 261.87M 281.39M
Current liabilities 117.24M 128.57M 118.66M 121.63M 137.38M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 9.76M -3.39M -1.96M 12.22M 15.48M
Investing cash flow -2.6M 1.11M -3.2M -4.16M -3.88M
Financing cash flow -3.64M 13.45M -979K -38.61M -14.47M
Change in cash 4.42M 13.09M -5.97M -28.24M -2.14M
Kind Filing Date Link
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — Fleming John Turman View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 144 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — Jones Paul A. View Filing
edgar index 144 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — IIEKKING G DOUG View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — FULLER GILBERT A View Filing
edgar index 8-K — USANA HEALTH SCIENCES INC View Filing
eight k text 8-K — 8-K View Filing
edgar index 10-Q — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 144 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — FULLER GILBERT A View Filing
form 4 Form 4 — WOOD TIMOTHY E View Filing
form 4 Form 4 — Winssinger Frederic J View Filing
form 4 Form 4 — Nixon J Scott View Filing
form 4 Form 4 — Foukas Joshua View Filing
form 4 Form 4 — Pelosi Peggie View Filing
form 4 Form 4 — Fleming John Turman View Filing
form 4 Form 4 — Ding Xia View Filing
edgar index 8-K — USANA HEALTH SCIENCES INC View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — FULLER GILBERT A View Filing
form 4 Form 4 — FULLER GILBERT A View Filing
form 4 Form 4 — WOOD TIMOTHY E View Filing
form 4 Form 4 — WOOD TIMOTHY E View Filing
form 4 Form 4 — WOOD TIMOTHY E View Filing
form 4 Form 4 — Winssinger Frederic J View Filing
form 4 Form 4 — Winssinger Frederic J View Filing
form 4 Form 4 — Nixon J Scott View Filing
form 4 Form 4 — Nixon J Scott View Filing
form 4 Form 4 — Pelosi Peggie View Filing
form 4 Form 4 — Pelosi Peggie View Filing
form 4 Form 4 — Pelosi Peggie View Filing
form 4 Form 4 — Fleming John Turman View Filing
form 4 Form 4 — Fleming John Turman View Filing
form 4 Form 4 — Ding Xia View Filing
form 4 Form 4 — Ding Xia View Filing
form 4 Form 4 — Ding Xia View Filing
edgar index DEF 14A — USANA HEALTH SCIENCES INC View Filing
edgar index ARS — USANA HEALTH SCIENCES INC View Filing
edgar index SCHEDULE 13D/A — USANA HEALTH SCIENCES INC View Filing
edgar index SCHEDULE 13G/A — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
form 4 Form 4 — FULLER GILBERT A View Filing
edgar index 10-K — USANA HEALTH SCIENCES INC View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 144 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing
edgar index 4 — USANA HEALTH SCIENCES INC View Filing